Legend Biotech (LEGN) Earnings Date, Estimates & Call Transcripts $31.58 -0.46 (-1.44%) As of 05/9/2025 03:52 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Legend Biotech Earnings Summary Legend Biotech released Q4 2024 earnings on March 11, 2025, reporting an EPS of $0.07, which beat analysts' consensus estimates of -$0.39 by $0.46. Quarterly revenue rose 134.6% year-over-year to $186.50 million, above analyst estimates of $179 million. With a trailing EPS of -$0.48, Legend Biotech's earnings are expected to grow next year, from ($1.31) to ($0.53) per share. Upcoming Earnings DateMay. 13Before Market OpensEstimatedConsensus EPS (Mar. 11) -$0.39 Actual EPS (Mar. 11) $0.07 Beat By $0.46 Actual Revenue (Mar. 11) $186.50MQ4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Annual Report (20-F)LEGN Upcoming EarningsLegend Biotech's Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Legend Biotech Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Legend Biotech and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLEGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LEGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Legend Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.40-$0.17-$0.29Q2 20252-$0.33$0.06-$0.14Q3 20252-$0.10-$0.06-$0.08Q4 20252-$0.03$0.10$0.04 FY 2025 8 -$0.86 -$0.07 -$0.47 Q1 20261$0.03$0.03$0.03Q2 20261$0.16$0.16$0.16Q3 20261$0.26$0.26$0.26Q4 20261$0.33$0.33$0.33 Legend Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)-------3/11/2025Q4 2024-$0.39$0.07+$0.46$0.07$179.00M$186.50M11/12/2024Q3 2024-$0.56-$0.34+$0.22-$0.34$143.91M$160.20M8/9/2024Q2 2024-$0.54-$0.05+$0.49-$0.05$125.25M$186.50M5/13/2024Q1 2024-$0.29-$0.16+$0.13-$0.16$143.24M$93.90M3/11/2024Q4 2023-$0.70-$0.40+$0.30-$0.40$95.63M$76.50M11/20/2023Q3 2023-$0.31-$0.17+$0.14-$0.17$97.25M$96.00M8/15/2023Q2 2023-$0.36-$0.57 -$0.21$0.03$56.64M$73.30M5/18/2023Q1 2023-$0.56-$0.40+$0.16-$0.46$37.06M$36.34M Legend Biotech Earnings - Frequently Asked Questions When is Legend Biotech's earnings date? Legend Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on LEGN's earnings history. Did Legend Biotech beat their earnings estimates last quarter? In the previous quarter, Legend Biotech (NASDAQ:LEGN) reported $0.07 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.39) by $0.46. Learn more on analysts' earnings estimate vs. LEGN's actual earnings. How can I listen to Legend Biotech's earnings conference call? The conference call for Legend Biotech's latest earnings report can be listened to online. Listen to Conference Call How can I read Legend Biotech's conference call transcript? The conference call transcript for Legend Biotech's latest earnings report can be read online. Read Transcript How much revenue does Legend Biotech generate each year? Legend Biotech (NASDAQ:LEGN) has a recorded annual revenue of $627.24 million. How much profit does Legend Biotech generate each year? Legend Biotech (NASDAQ:LEGN) has a recorded net income of -$518.25 million. LEGN has generated -$0.48 earnings per share over the last four quarters. What is Legend Biotech's EPS forecast for next year? Legend Biotech's earnings are expected to grow from ($1.31) per share to ($0.53) per share in the next year. More Earnings Resources from MarketBeat Related Companies BNTX Earnings Results SMMT Earnings Results TEVA Earnings Results ITCI Earnings Results GMAB Earnings Results RDY Earnings Results MRNA Earnings Results ASND Earnings Results VTRS Earnings Results QGEN Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming?DexCom Stock: Earnings Beat and New Market Access Drive Bull CaseDisney Stock Jumps on Earnings—Is the Magic Sustainable? This page (NASDAQ:LEGN) was last updated on 5/10/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredWarning: Massive IPO Predicted for May 14?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Remember when they said crypto would never go mainstream? Well, something remarkable has happened… Blac...Crypto 101 Media | SponsoredThis robot is coming to 65 million Americans … this year.The Robotics Revolution has arrived. And not surprisingly, Nvidia is leading the way. Nvidia CEO Jensen ...Weiss Ratings | Sponsored[FREE GIFT] New AI for retail tradersTradeAlgo has found a “backdoor way” for retail traders to profit from the AI arms race by developing its grou...TradeAlgo | SponsoredOne Stock Gold Blueprint to Survive the Market ChaosOne Stock Gold Blueprint to Survive the Market Chaos Markets are volatile, uncertainty is everywhere, and A...InvestorPlace | SponsoredNew Global Crisis Threatens U.S. RetirementsA new global crisis has just detonated… fueled by escalating trade wars and aggressive moves by evil foreign p...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.